|
Also Recommended
|
|
|
Mellar P. Davis, Paul A. Glare...
£60.00
|
|
|
|
|
Highly commended in the Oncology Category of the BMA Book Awards 2009
Prognosis in Advanced Cancer
Edited by Paul Glare and Nicholas A Christakis
456 pages
|
47 black and white line illustrations and 14 black and white photographs
|
246x171mm
978-0-19-853022-0
|
Paperback
|
20 March 2008
Price:
£60.00 £15.00
Please note, this offer price only applies to individual customers when ordering direct from Oxford University Press, while stock lasts. No further discounts will apply. If you are a bookseller, please contact your OUP sales representative.
|
|
|
|
|
- A comprehensive guide to the prognosis of palliative care conditions
- Includes principles of prognosis, covering formulating the prediction and communicating it with ethical considerations
- Written to aid quick navigation, so information on natural history, prognostic factors, effects of treatment, and short and long term outlooks for various cancers can be easily found
- Features a quick reference summary table of short and long term prognosis, and survival curves to assist the reader
Predicting survival and other outcomes is increasingly being recognized as an important skill for palliative care doctors and nurses, oncologists, and other healthcare professionals who treat patients with advanced cancer. Accurate prognosis is essential if we are to offer quality of care and 'a good death', as well as to aid decision-making. There is much prognostic information available that is scattered throughout the palliative care and oncological literature but this is the first time it has been gathered systematically in one place.
Glare and Christakis, leaders in the
field of prognosis, bring together a team of international contributors from across the fields of palliative care and oncology. This comprehensive but practical guide begins with the principles of prognostication, including formulating the prediction and then communicating it. Topics such as statistical issues, evidence-based medicine, and the ethics of prognostication are also covered. The second section addresses prognostication in 15 specific cancer sites once they have reached the advanced stage, following a standard template for consistency and easy access to the key information. The third section deals with prognostication in patients with a variety of common clinical conditions at the end of life, such as bowel obstruction, hypercalcaemia, and brain metastases. In addition,
survival curves are provided within each chapter, palliative care conditions are examined for the first time, and a summary table of long and short term prognosis ensures this book remains practical. Readership: Palliative care doctors and nurses, oncologists, and anyone caring for a patient towards the end of life.
|
|
|
Edited by Paul Glare, Head of Palliative Care, Sydney Cancer Centre, Royal Prince Alfred Hospital; Clinical Associate Professor, Central Clinical School (Medicine), Faculty of Medicine, University of Sydney, Australia, and Nicholas A Christakis, Professor, Department of Health Care Policy, Harvard Medical School; Department of Medicine, Mt. Auburn Hospital, Boston, USA Contributors:
Lara Alloway, Consultant in Palliative Medicine, North Hampshire Palliative Care Service, Basingstoke, UK
Laura Biganzoli, Head, Clinical Research Unit, Sandro Pitigliani Medical Oncology Unit,
Hospital of Prato, Istituto
Toscano Tumori, Italy
Murray F. Brennan, Attending Surgeon, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
Andrew Broadbent, Director of Palliative Care, Hope Healthcare North, Greenwich, Sydney, Australia
Bert Broeckaert, Director, Interdisciplinary Centre for Religious Studies, Faculty of Theology, K.U. Leuven Sint-Michielsstraat 6 3000 Leuven, Belgium
Eduardo Bruera, Professor and Chair, Department of Palliative Care and Rehabilitation Medicine, The University of Texas, MD Anderson Cancer Center, Houston, USA
Cinzia Brunelli, Statistician, Unit of Rehabilitation & Palliative Care, Istituto Nazionale Tumori, Milan, Italy
Markus W. Büchler, Head of the Department of Surgery, University
Hospital, Heidelberg, Germany
Phyllis Butow, Professor, NHMRC Priniciple Research Fellow and Director Medical Psychology Research Unit, University of Sydney, Australia
Angela Byrne, Fellow in Cross-sectional Imaging, Beaumont Hospital, Dublin, Ireland
Jonathan Carter, Professor Gynaecological Oncology, The University of Sydney; Head, Sydney Gynaecological Oncology Group, Sydney Cancer Centre; Head, Gynaecology Services, Royal Prince Alfred Hospital; Area Director, Gynaecological Oncology, Sydney South West Area Health Service, Sydney, Australia
Eric L. Chang, Associate Professor of Radiation Oncology, Department of Radiation Oncology, Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, USA
Edward Chow, Associate Professor, Department of Radiation Oncology, Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Canada
Nicholas Christakis, Professor, Department of Health Care Policy, Harvard Medical School; Department of Medicine, Mt. Auburn Hospital, Boston, USA
Katherine Clark, Senior Staff Specialist, Department of Palliative Care, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia
David Currow, Director, Southern Adelaide Palliative Services; Chair, Department of Palliative and Supportive Services, Flinders University, Adelaide, Australia
Mellar P. Davis, The Harry H. Horvitz Center for Palliative Medicine, Taussig Cancer Center, Cleveland Clinic, Cleveland, USA
Jonathan E.
Dowell, Chief, Hematology/Oncology, Dallas Veterans Affairs Medical Center; Associate Professor of Internal Medicine, University of Texas-Southwestern, Dallas, USA
Charles Dumontet, Services d'Hématologie, Hopital Edouard Herriot, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon, France
Fabio Efficace, Head, Health Outcome Research Unit, Italian Group for Adult Hematologic Diseases ( (GIMEMA), GIMEMA Data Center, University of Rome "La Sapienza", Department of Cellular Biotechnology and Hematology, Rome, Italy
Miriam Friedlander, Instructor, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, USA
Tony Geoghegan, Lecturer in Radiology, The Department of
Academic Radiology, Beaumont Hospital, Dublin, Ireland
Timothy Gilligan, Urologic Oncology Program, Cleveland Clinic Taussig Cancer Center, Cleveland, USA
Phyllis A. Gimotty, Professor of Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA
Paul Glare, Head of Palliative Care, Sydney Cancer Centre, Royal Prince Alfred Hospital; Clinical Associate Professor, Central Clinical School (Medicine), Faculty of Medicine, University of Sydney, Australia
Rebecca Hagerty, PhD Research Co-ordinator, Medical Psychology Research Unit, University of Sydney, Australia
Anne Hamilton, Senior Staff Specialist, Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital,
Sydney, Australia
Irene Higginson, Professor of Palliative Care and Policy, Department of Palliative Care, Policy and Rehabilitation, King's College London, United Kingdom
George Hruby, Clinical Senior Lecturer, Department of Radiation Oncology, Sydney Cancer Centre, University of Sydney, Australia
Ceri Hughes, Consultant Maxillofacial / Head & Neck Surgeon, Department of Maxillofacial / Head & Neck Surgery, United Bristol Healthcare Trust, Bristol, UK
Vicki Jackson, MPH Instructor in Medicine, Harvard Medical School; Associate Director of the Palliative Care Service, Massachusetts General Hospital, Boston, USA
Aminah Jatoi, Associate Professor, Department of Oncology, Mayo Clinic, Rochester, USA
Vaughan
Keeley, Consultant in Palliative Medicine, Derby Hospitals NHS Foundation Trust, Nightingale Macmillan Unit, Derby, UK
David Kissane, Chairman, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, USA
Moritz Koch, Attending, Department of Surgery, University Hospital, Heidelberg, Germany
Sunil Krishnan, Assistant Professor, Department of Radiation Oncology, M.D. Anderson Cancer Center, Houston, USA
Elizabeth B. Lamont, Assistant Physician, Massachusetts General Hospital Cancer Center; Assistant Professor, Departments of Health Care Policy and Medicine, Harvard Medical School, Boston, USA
Michael J. Lee, Professor of Radiology, Department of Radiology, Beaumont Hospital and the Royal
College of Surgeons in Ireland, Dublin, Ireland
Edward Lin, red Hutchison Cancer Center, Department of Hematology Oncology, University of Washington, Seattle, USA
William J. Mackillop, Professor and Chair, Department of Community Health and Epidemiology, Queen's Universtity, Kingston, Canada
Anita Mahajan, Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, USA
Marco Maltoni, Palliative Care Unit, Oncology Department, GB.Morgagni-L.Pierantoni Hospital, Forlì, Italy
Sebastiano Mercadante, Professor of Palliative Medicine, University of Palermo;
Director of Anesthesia & Intensive Care and, Pain Relief & Palliative Care, La Maddalena Cancer Center, Palermo, Italy
Ian E. McCutcheon, Professor of neurosurgery, Department of Neurosurgery, University of Texas, M. D. Anderson Cancer Center, Houston, USA
Maria Montoya, Department of Palliative Care and Rehabilitation Medicine, The University of Texas, MD Anderson Cancer Center, Houston, USA
Katherine T. Morris, Surgical Oncologist and Medical Director of Cancer Research and Hepatobiliary Programs, Legacy Health System, NW Surgical Oncology PC, Portland, USA
Lida Nabati, Instructor in Medicine, Harvard Medical School; Attending Physician, Pain and Palliative Care Service, Dana-Farber Cancer Institute, Boston, USA
Kelvin K. Ng, Associate Consultant, Department of Surgery, Queen Mary Hospital, Hong Kong, China
Phuong L. Nguyen, Department of
Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
Hiroko Ohgaki, Head, Pathology Group, International Agency for Research on Cancer, Lyon, France
Martin Pecherstorfer, Specialist in Haematology and Oncology Department of Medicine, Center for Hematology and Oncology, Wilhelminenspital der Stadt Wien, Vienna, Austria
Nora Janjan, Professor of Radiation Oncology, Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, USA
Jay F. Piccirillo, Director, Clinical Outcomes Research Office, Department of Otolaryngology, Head and Neck Surgery, Washington University School of Medicine, St Louis, USA
Ronnie T.P. Poon, Professor of Surgery, Department of Surgery, The University of Hong
Kong, Queen Mary Hospital, Hong Kong, China
Christine Sanderson, Senior Registrar, Southern Adelaide Palliative Services, Australia
Luigi Schips, Chief, Department of Urology, Ospedale "S.Pio da Pietrelcina"-Vasto, ITALY
Martin R Stockler, Associate Professor and Co-Director of Cancer Trials, NHMRC Clinical Trials Centre, University of Sydney; Consultant Medical Oncologist, Sydney Cancer Centre - RPA & Concord Hospitals, Sydney, Australia
C. Martin Tammemagi, Associate Professor, Department of Community Health Sciences, Brock University, St. Catharines, Canada
Martin HN Tattersall, Professor of Cancer Medicine, University of Sydney, Australia
Catherine Thieblemont, Services d'Hématologie, Hopital Edouard Herriot,
Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon, France
Steven J Thomas, Consutlant Head and Neck Surgeon and Head of Division of Maxillofacial Surgery, University of Bristol and United Bristol Health Care Trust, United Kingdom
Anna Vlahiotis, Clinical Outcomes Research Office, Department of Otolaryngology, Head and Neck Surgery, Washington University School of Medicine, St Louis, USA
Jürgen Weitz, Head of Section of Surgical Oncology, Department of Surgery, University Hospital, Heidelberg, Germany
Tugba Yavuzsen, Research Fellow, The Harry H. Horvitz Center for Palliative Medicine, Department of Hematology, Medical Oncology, The Cleveland Clinic Foundation, Cleveland, USA
Albert JM Yee,
Assistant Professor, Department of Surgery, University of Toronto
Division of Orthopaedic Surgery, Sunnybrook Health Sciences Centre; Consultant, Surgical Oncology, Centre for the Study on Bone Metastases, Toronto Sunnybrook Regional Cancer Centre, Canada
Richard Zigeuner, Department of Urology, Medical University Graz, Austria
Niklas Zojer, Consultant, Department of Medicine, Center for Oncology and Hematology, Wilhelminenspital, Vienna, Austria
|
|
|
"...the quality of this book is outstanding...very necessary for physicians and other medical personnel." - Marlene S. Foreman, BSN, Hospice of Acadiana, Inc.
|
|
|
PART 1: SCIENCE OF PROGNOSTICATION
1: Paul Glare and Nicholas Christakis: Overview: advancing the clinical science of prognostication
2: William J. Mackillop: Differences in prognostication between early stage cancer and advanced cancer
3: Elizabeth B. Lamont: Foreseeing: formulating an accurate prognosis
4: Phyllis Butow, Rebecca Hagerty, Martin Tattersall, and Martin Stockler: Foretelling: communicating the prognosis
5: Phyllis A. Gimotty: Statistical concepts and issues related to prognostic models
6: Paul Glare, Marco Maltoni and Cinzia Brunelli: Evidence based medicine
7: Jay F. Piccirillo and Anna Vlahiotis: Tools for formulating prognosis
8: Bert Broeckaert and Paul Glare: Ethics
PART 2: PROGNOSTICATION IN SPECIFIC CANCERS
9: C. Martin Tammemagi: Lung cancer
10: Tony Geoghegan and Michael J. Lee: Colorectal cancer
11: Fabio Efficace and Laura Biganzoli: Breast cancer
12: Luigi Schips and Richard Zigeuner: Bladder cancer
13: Timothy Gilligan: Prognosis of prostate cancer
14: Moritz Koch, Jürgen Weitz and Markus W. Büchler: Pancreatic cancer
15: Kelvin K. Ng and Ronnie T. Poon: Hepatoma
16: Ceri Hughes and Steve Thomas: Head and neck cancer
17: Jonathan Carter: Gynaecological cancer
18: Hiroko Ohgaki: Brain cancer
19: Charles Dumontet and Catherine Thieblemont: Non-Hodgkin's Lymphoma (NHL)
20: Paul Glare: Leukaemia and myeloma
21: Katherine T. Morris and Murray F. Brennan: Sarcoma
22: Jonathan Dowell: Unknown primary
23: Anne Hamilton and Katherine Clark: Melanoma
PART 3: PROGNOSIS IN PALLIATIVE CARE
24: Edward Chow and Albert Yee: Bone secondaries
25: Andrew Broadbent and George Hruby: Brain secondaries
26: Vicki Jackson and Lida Nabati: Leptomeningeal disease
27: Angela Byrne and Michael Lee: Liver metastases
28: David Currow and Christine Sanderson: Lung secondaries
29: Niklas Zojer and Martin Pecherstorfer: Hypercalcemia
30: Nora Janjan, Anita Mahajan, Eric L. Chang, Edward Lin, Sunil Krishnan, and Edward Chow: Spinal cord compression
31: Maria Montoya and Eduardo Bruera: Pain relief
32: Sebastiano Mercadante: Malignant bowel obstruction
33: Lara Alloway, Vaughan Keeley and Irene Higginson: Breathlessness
34: Miriam Friedlander and David Kissane: Delirium
35: Aminah Jatoi: Weight loss
36: Tugba Yavuzsen and Mellar P. Davis: Fatigue
|
|
|
|
|
|
|
|
|
Recently Viewed
|
|
|
£7.99
|
|
|
|
|
William Walton, David Lloyd-Jones...
Vocal and instrumental scores and parts on hire - large orchestra
Available on Hire
|
|
|
|
|
Colin Hay, Anand Menon
£27.99
|
|
|
|
|
The specification in this catalogue, including without limitation price, format, extent, number of illustrations, and month of publication, was as accurate as possible at the time the catalogue was compiled. Occasionally, due to the nature of some contractual restrictions, we are unable to ship a specific product to a particular territory. Jacket images are provisional and liable to change before publication.
|
|
